Pfizer settles U.S. marketing case related to Rapamune
WASHINGTON (Reuters) - Pfizer Inc will pay $490.9 million to resolve accusations of illegal marketing of the drug Rapamune dating to Pfizer's 2009 acq...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/vPvaCPmnW1A/story01.htm
No comments:
Post a Comment